Hologic completes BioLucent purchase

AuntMinnie.com staff writers
Sep 19, 2007

Women's imaging vendor Hologic of Bedford, MA, has completed its acquisition of mammography pad developer BioLucent of Aliso Viejo, CA.

Hologic announced in June that it was planning to buy BioLucent for $70 million in cash and stock, including a $15 million earn-out if financial targets are met. The company hopes that BioLucent's MammoPad breast cushion will become the standard of care in mammography studies, according to Hologic executives.

By AuntMinnie.com staff writers
September 20, 2007

Related Reading

Hologic achieves record quarter, July 31, 2007

AIE wins Hologic licensing agreement, July 19, 2007

Hologic to buy mammo pad firm BioLucent, June 22, 2007

Hologic to buy Cytyc in $6.2 billion deal that unites women's health companies, May 21, 2007

Hologic notches record growth in Q2, May 1, 2007

Copyright © 2007 AuntMinnie.com

Latest in Breast
Breast Mol
FES-PET could save $142M in breast cancer costs
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
May 17, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
May 6, 2024
Breast Cancer3
DBT + CEM boosts cancer detection in women with history of the disease
April 30, 2024
Related Stories
2007 08 29 12 38 25 706
Breast
New CR technology boosts resolution, bags R&D award
2007 07 26 11 56 35 706
Breast
Mammography effectively detects recurrent DCIS postradiotherapy
2007 06 20 16 36 13 706
Breast
The parallax view: Digital breast tomosynthesis has cancer screening in its crosshairs
2007 05 23 16 21 14 706
Breast
Studies show CAD matches up well with CR mammo, FFDM
More in Breast
FES-PET could save $142M in breast cancer costs
By Will Morton
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor-positive breast cancer could save millions.
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
By Will Morton
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma.
May 17, 2024
Breast Mol
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
By Liz Carey
A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.
May 6, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
USPSTF finalizes breast cancer screening recommendations
By Liz Carey
The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.
April 30, 2024
Mammogram Breast
Large language models underperform in breast imaging
By Amerigo Allegretto
Large language models such as ChatGPT and Google Gemini fall short in breast imaging.
April 30, 2024
Screenshot (1152)
U.S. federally qualified health centers show cancer screening gaps
By Kate Madden Yee
U.S. federally qualified health centers, intended to provide care to underserved populations across the country, show cancer screening gaps.
April 29, 2024
Breast Screening Mammo
RadNet teams up with basketball icon Sheryl Swoopes
By AuntMinnie.com staff writers
RadNet has tapped basketball legend and WNBA superstar Sheryl Swoopes as spokesperson for its nationwide breast cancer screening programs.
April 12, 2024
Mammogramnow
AI can be used to 'rule-out' breast cancer on mammography
By Erik L. Ridley
A deep-learning algorithm can rule out the presence of breast cancer on screening mammograms, improving specificity and yielding significant workflow and downstream savings.
April 10, 2024
Artificial Intelligence Ai Binary Code
AI helps select patients for supplemental breast cancer screening
By Erik L. Ridley
An AI-based method can outperform breast density measurements for flagging patients who would benefit from supplemental breast cancer screening.
April 9, 2024
Breast Cancer 3 D
Cryoablation effective in women with breast cancer
By Will Morton
A minimally invasive procedure called cryoablation that uses ice to freeze and destroy tumors has proven effective for women with large breast cancer tumors.
March 27, 2024
Breast Update
FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer
By Will Morton
PET/CT imaging using gallium-68 FAPI radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma.
March 15, 2024
Maximum-intensity projection F-18 FDG-PET (left) and Ga-68 FAPI-PET (right) images of synchronous ILC. (A) A 42-year-old patient with multicentric primary lesions (encircled), regional (solid arrows), and distant inferior jugular lymph node (dashed arrows) seen on F-18 FDG-PET and subsequently confirmed on Ga-68 FAPI-PET, which also revealed additional malignant foci aligned with MRI. Some lesions exhibited high activity retention on Ga-68 FAPI-PET. (B) A 53-year-old patient showing no significant uptake on F-18 FDG-PET but synchronous bilateral lesions (arrows) on Ga-68 FAPI-PET, which also identified pathologic lymph nodes (encircled), resulting in upstaging. Image courtesy of the Journal of Nuclear Medicine.
Page 1 of 570
Next Page